Delivery Order SPE2DB20D3505-SPE2DB23FT7G4
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.80 firm fixed-price contract is for the supply of Lantus SoloStar 100 unit/mL 3mL, a type of insulin medication. The contract has an ultimate completion date of March 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication. The contract has a ceiling value of $2,375.20 and a completion date of August 7, 2024. This award is a firm fixed price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,326.23, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract has a final completion date of March 19, 2025 and is a Firm Fixed Price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin medication. The contract has a ceiling value of $1,291.10 and a performance period through April 16, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order under the Amerisourcebergen Drug Corp's (Amerisourcebergen) Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a prescription insulin product, to an unspecified location. The order has a ceiling value of $5,169.50 and is a firm fixed-price contract. Amerisourcebergen, a major pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lantus SoloStar, a 100 unit/mL, 3 mL insulin medication, with a ceiling value of $4,380.08. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 17, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The contract is for the delivery of 4,564,571,290 units of Lantus Solostar 100 unit/mL 3mL, a prescription insulin medication. The contract has a ceiling value of $1,420.88 and an ultimate completion date of May 13, 2024. This delivery order is issued against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin product. The contract has a ceiling value of $4,123.00 and runs through September 20, 2023. It is a firm fixed-price contract. There is no set-aside designation, indicating the contract was awarded through open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus SoloStar insulin medication, a diabetes treatment, with a ceiling value of $1,022.80. The contract is a firm fixed-price delivery order, with a performance period ending on May 2, 2025. This contract is not set-aside and was awarded on May 1, 2025. AmerisourceBergen Drug...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the procurement of Lantus SoloStar 100 unit/mL 3mL insulin delivery devices. The contract has a ceiling value of $1,381.48 and is a firm fixed price delivery order contract with a period of performance through March 12, 2025. There is no set-aside designation on this award. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FT7G4Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Lantus SoloStar 100 unit/mL 3mL, a prescription insulin medication. The contract is a firm-fixed-price delivery order with a ceiling value of $1,724.09 and a completion date of February 17, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 2/16/23 |